Bevacizumab and hypertension Patient Reports February 10, 2012

Bevacizumab Side Effects Report #5985133-0
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 03, 2008. Female patient was diagnosed with retinal vein occlusion and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: hypertension. Bevacizumab dosage: 1.25 MG, UNK. Patient recovered.

Bevacizumab Side Effects Report #5765289-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on June 09, 2008. Female patient, weighting 101.4 lb, was diagnosed with renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain

, diarrhoea, hypertension, hypothyroidism, nausea

. Bevacizumab dosage: 15 MG/KG (690 MG) Q 21 DAYS IV. During the same period patient was treated with BORTEZOMIB. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5990523-6
Bevacizumab side effect was reported by a Physician from UNITED STATES on Dec 03, 2008. Male patient was diagnosed with renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: hypertension, palmar-plantar erythrodysaesthesia syndrome. Bevacizumab dosage: 5 MG/KG, UNK. During the same period patient was treated with SORAFENIB. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5565696-X
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Dec 05, 2007. Male patient was diagnosed with rectal cancer recurrent and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: aortic dissection, hypertension. Bevacizumab dosage: 5 MG/KG, QD. During the same period patient was treated with OXALIPLATIN, ISOVORIN, FLUOROURACIL, ETODOLAC, FENTANYL, TEGRETOL, PRIMPERAN. Patient recovered.

Bevacizumab Side Effects Report #5586945-8
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Dec 27, 2007. Male patient was diagnosed with rectal cancer recurrent, cancer pain and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: aortic dissection, hypertension. Bevacizumab dosage: 5 MG/KG, QD. During the same period patient was treated with OXALIPLATIN, ISOVORIN, FLUOROURACIL, TEGRETOL, ETODOLAC, FENTANYL, PRIMPERAN. Patient recovered.

Bevacizumab Side Effects Report #5842264-3
Bevacizumab side effect was reported by a Consumer or non-health professional from JAPAN on July 29, 2008. Male patient was diagnosed with rectal cancer recurrent and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, epistaxis, hypertension, neutrophil count decreased. Bevacizumab dosage: 5 MG/KG, QD. During the same period patient was treated with IRINOTECAN, FLUOROURACIL, ISOVORIN, PARIET, LOXOPROFEN, OXYCONTIN, KYTRIL, DEXAMETHASONE PHOSPHATE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6065377-2
Bevacizumab side effect was reported by a Physician from JAPAN on Jan 22, 2009. Male patient, weighting 145.5 lb, was diagnosed with rectal cancer recurrent and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, gastrointestinal haemorrhage, hypertension. Bevacizumab dosage: 5 MG/KG, QD. During the same period patient was treated with ELPLAT, FLUOROURACIL, CALCIUM LEVOFOLINATE, IRINOTECAN HYDROCHLORIDE, MECOBALAMINE, LEUCON, LOXONIN, OXYCONTIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6121799-2
Bevacizumab side effect was reported by a Physician from JAPAN on Mar 06, 2009. Male patient, weighting 145.5 lb, was diagnosed with rectal cancer recurrent and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, gastrointestinal haemorrhage, hypertension. Bevacizumab dosage: 5 MG/KG, QD. During the same period patient was treated with ELPLAT, FLUOROURACIL, CALCIUM LEVOFOLINATE, IRINOTECAN HYDROCHLORIDE, MECOBALAMINE, LEUCON, LOXONIN, OXYCONTIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5487237-8
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Oct 01, 2007. Female patient was diagnosed with rectal cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: headache

, hypertension, renal failure, reversible posterior leukoencephalopathy syndrome. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with ELOXATIN, LEUCOVORIN, FLUOROURACIL, LASIX, LISINOPRIL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5585831-7
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Dec 26, 2007. Male patient was diagnosed with rectal cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: altered state of consciousness, hypertension. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with IRINOTECAN, ISOVORIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5654356-2
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 20, 2008. Male patient was diagnosed with rectal cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaphylactic shock, hypertension, pelvic abscess. Bevacizumab dosage: 10 MG/KG, QD. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, ISOVORIN. Patient recovered.

Bevacizumab Side Effects Report #5758726-3
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on May 20, 2008. Female patient was diagnosed with rectal cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: hypertension, nervous system disorder, neutrophil count decreased. Bevacizumab dosage: 5 MG/KG, QD. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, ISOVORIN, IRINOTECAN, AMLODIPINE BESYLATE, NAPROXEN, CANDESARTAN CILEXETIL, ZANTAC. Patient recovered.

Bevacizumab Side Effects Report #5774580-8
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on June 02, 2008. Male patient was diagnosed with rectal cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaphylactic shock, hypertension, pelvic abscess. Bevacizumab dosage: 10 MG/KG, QD. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, ISOVORIN, LOXONIN. Patient recovered.

Bevacizumab Side Effects Report #5846810-5
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Aug 01, 2008. Male patient was diagnosed with rectal cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaphylactic shock, hypertension, pelvic abscess. Bevacizumab dosage: 10 MG/KG, QD. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, ISOVORIN, LOXONIN, GRANISETRON. Patient recovered.

Bevacizumab Side Effects Report #5853340-3
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Aug 06, 2008. Female patient, weighting 79.37 lb, was diagnosed with rectal cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: hypertension, nervous system disorder, neutrophil count decreased. Bevacizumab dosage: 5 MG/KG, QD. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, ISOVORIN, IRINOTECAN, AMLODIPINE BESYLATE, NAIXAN, BLOPRESS, ZANTAC. Patient recovered.

Bevacizumab Side Effects Report #6121272-1
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 02, 2009. Male patient was diagnosed with pleural mesothelioma malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: hypertension, neutropenia, renal failure. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with PEMETREXED, CISPLATIN, SPECIAFOLDINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #4999871-X
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Apr 21, 2006. Female patient, 63 years of age, weighting 149.9 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain

, acute respiratory distress syndrome, diffuse alveolar damage, hypertension, lethargy, metabolic acidosis, pyrexia, sinus tachycardia. Bevacizumab dosage: 340 MG, Q2W, INTRAVENOUS. During the same period patient was treated with ERLOTINIB, GEMCITABINE, LISINOPRIL. Patient was hospitalized. Patient died on 03/10/2006.

Bevacizumab Side Effects Report #5782559-5
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on June 09, 2008. Female patient was diagnosed with ovarian epithelial cancer, ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: confusional state, hypertension, nausea

. Bevacizumab dosage: 387 MG, Q3W. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, ASPIRIN, ATORVASTATIN, BENDROFLUAZIDE, CALCICHEW, CITALOPRAM HYDROBROMIDE, DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5911508-1
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Sept 23, 2008. Female patient was diagnosed with ovarian epithelial cancer, ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: confusional state, hypertension, nausea

. Bevacizumab dosage: 387 MG, Q3W. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, ASPIRIN, ATORVASTATIN, BENDROFLUAZIDE, CALCICHEW, CITALOPRAM HYDROBROMIDE, DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5985129-9
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 26, 2008. Female patient was diagnosed with ovarian epithelial cancer, ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: confusional state, hypertension, nausea

. Bevacizumab dosage: 387 MG, Q3W. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, ASPIRIN, ATORVASTATIN CALCIUM, BENDROFLUAZIDE, CALCICHEW, CITALOPRAM HYDROBROMIDE, DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6023619-3
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Dec 17, 2008. Female patient was diagnosed with ovarian epithelial cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: hypertension, hyponatraemia, hypotension, syncope. Bevacizumab dosage: 427 MG, Q3W. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, CILAZAPRIL, METOPROLOL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6110640-X
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Feb 24, 2009. Female patient was diagnosed with ovarian epithelial cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: hypertension, hyponatraemia, hypotension, syncope. Bevacizumab dosage: 427 MG, Q3W. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, CILAZAPRIL, METOPROLOL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5488616-5
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Oct 03, 2007. Female patient, weighting 175.7 lb, was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: hypertension. Bevacizumab dosage: 600 MG, UNK. During the same period patient was treated with PACLITAXEL, CARBOPLATIN, LISINOPRIL AND HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5143788-7
Bevacizumab side effect was reported by a Pharmacist from UNITED STATES on Nov 01, 2006. Male patient, 66 years of age, weighting 219.0 lb, was diagnosed with osteitis deformans and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion, hypertension, mental status changes, reversible posterior leukoencephalopathy syndrome. Bevacizumab dosage: 1500MG Q3WKS IV. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #4983711-9
Bevacizumab side effect was reported by a Pharmacist from UNITED STATES on Apr 25, 2006. Female patient, weighting 158.7 lb, was diagnosed with non-small cell lung cancer stage iv and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: cerebrovascular accident, grand mal convulsion, haemorrhage intracranial, hypertension. Bevacizumab dosage: 1000MG -15MG/KG- Q3 WEEKS IV DRIP. Patient recovered.

Bevacizumab Side Effects Report #4967125-3
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 17, 2006. Female patient, 64 years of age, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, arteriosclerosis, blood pressure increased, confusional state, convulsion, hypertension, hypertensive encephalopathy, hypokalaemia, malignant neoplasm progression. Bevacizumab dosage: unknown. During the same period patient was treated with PACILTAXEL, ACETAMINOPHEN, LABETALOL, ROCEPHIN, TOPROL, LISINOPRIL, AMPICILLIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5252909-7
Bevacizumab side effect was reported by a Physician from FRANCE on Feb 07, 2007. Female patient, 58 years of age, weighting 165.3 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, blood pressure decreased, condition aggravated, disease progression, hypertension, international normalised ratio increased, thrombosis. Bevacizumab dosage: unknown. During the same period patient was treated with CISPLATIN, GEMCITABINE, LOVENOX, RABEPRAZOLE, ATACAND, ATENOLOL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5639515-7
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 11, 2008. Female patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: chest pain

, hypertension, oedema peripheral. Bevacizumab dosage: 810 MG, QD. During the same period patient was treated with ERLOTINIB. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5975295-3
Bevacizumab side effect was reported by a Physician from UNITED STATES on Nov 21, 2008. Female patient, weighting 89.98 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: cerebral atrophy, confusional state, encephalopathy, hypertension. Bevacizumab dosage: 15 MG/KG, UNK. During the same period patient was treated with PEMETREXED, CARBOPLATIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6018735-6
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 12, 2008. Female patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: hypertension, palmar-plantar erythrodysaesthesia syndrome, proteinuria. Bevacizumab dosage: 15 MG/KG, UNK. During the same period patient was treated with TAXOL, CARBOPLATIN, LEVOTHYROXINE, NOVALGIN. Patient recovered.

Bevacizumab Side Effects Report #5655819-6
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 29, 2008. Male patient, weighting 147.7 lb, was diagnosed with nasopharyngeal cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: hypertension, mucosal inflammation. Bevacizumab dosage: 15 MG/KG, UNK. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5663285-X
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 06, 2008. Male patient, weighting 147.7 lb, was diagnosed with nasopharyngeal cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: hypertension, mucosal inflammation. Bevacizumab dosage: 15 MG/KG, UNK. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5673790-8
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 11, 2008. Male patient, weighting 147.7 lb, was diagnosed with nasopharyngeal cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: hypertension, mucosal inflammation. Bevacizumab dosage: 15 MG/KG, UNK. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6012477-9
Bevacizumab side effect was reported by a Physician from UNITED STATES on Dec 03, 2008. Male patient was diagnosed with nasopharyngeal cancer, hyponatraemia and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: hypertension, hyponatraemia, supraventricular tachycardia. Bevacizumab dosage: 15 MG/KG, UNK. During the same period patient was treated with CISPLATIN, CHLORIDE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6068552-6
Bevacizumab side effect was reported by a Physician from INDIA on Jan 26, 2009. Male patient, weighting 77.16 lb, was diagnosed with metastatic renal cell carcinoma, prophylaxis, insomnia, pain

and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: hypertension. Bevacizumab dosage: unknown. During the same period patient was treated with DOMPERIDONE, LORAZEPAM, PANTOPRAZOLE, INTERFERON ALFA, ULTRACET. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6073651-9
Bevacizumab side effect was reported by a Physician from INDIA on Feb 09, 2009. Male patient, weighting 77.16 lb, was diagnosed with metastatic renal cell carcinoma, prophylaxis, insomnia, pain

and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: hypertension. Bevacizumab dosage: unknown. During the same period patient was treated with DOMPERIDONE, LORAZEPAM, PANTOPRAZOLE, INTERFERON ALFA, ULTRACET. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6085699-9
Bevacizumab side effect was reported by a Physician from INDIA on Feb 12, 2009. Male patient, weighting 81.57 lb, was diagnosed with metastatic renal cell carcinoma, prophylaxis, insomnia, pain

and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: hypertension. Bevacizumab dosage: unknown. During the same period patient was treated with DOMPERIDONE, LORAZEPAM, PANTOPRAZOLE, INTERFERON ALFA, ULTRACET. Patient recovered.

Bevacizumab Side Effects Report #4630249-4
Bevacizumab side effect was reported by a Health Professional from on Apr 05, 2005. Male patient, 66 years of age, was diagnosed with metastatic neoplasm and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: headache

, hypertension. Bevacizumab dosage: 15 MG/KG EVERY 21 DAYS IV. During the same period patient was treated with LISINOPRIL, PREVACID, COREG, SANDOSTATIN, CATAPRES, PROTINEX, ASPIRIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5847128-7
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on July 31, 2008. Male patient was diagnosed with metastatic malignant melanoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diabetes mellitus, gastroenteritis salmonella, hypertension, pyrexia. Bevacizumab dosage: 800 MG, Q2W. During the same period patient was treated with TEMODAL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5852708-9
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Aug 08, 2008. Male patient was diagnosed with metastatic malignant melanoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diabetes mellitus, gastroenteritis salmonella, hypertension, pyrexia. Bevacizumab dosage: 800 MG, Q2W. During the same period patient was treated with TEMODAL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5746990-6
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on May 07, 2008. Male patient was diagnosed with malignant melanoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diabetes mellitus, gastroenteritis salmonella, hypertension, pyrexia. Bevacizumab dosage: 800 MG, Q2W. During the same period patient was treated with TEMODAL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5761766-1
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on May 23, 2008. Male patient was diagnosed with malignant melanoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diabetes mellitus, gastroenteritis salmonella, hypertension, pyrexia. Bevacizumab dosage: 800 MG, Q2W. During the same period patient was treated with TEMODAL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5827378-6
Bevacizumab side effect was reported by a Physician from UNITED STATES on July 22, 2008. Male patient, weighting 334.9 lb, was diagnosed with malignant melanoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: hypertension, small intestinal obstruction, vomiting. Bevacizumab dosage: 15 MG/KG, Q21D. During the same period patient was treated with LORTAB, REGLAN, ALTACE, ZOFRAN, FERROUS SULPHATE, BENTYL, SUPPLEMENTS. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5499798-3
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Oct 23, 2007. Male patient, 78 years of age, was diagnosed with hepatic neoplasm malignant, hypertension and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation

, hypertension. Bevacizumab dosage: 10 MG/KG, Q2W. During the same period patient was treated with ERLOTINIB, LISINOPRIL, LOSARTAN POTASSIUM, NADOLOL, NEXIUM. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5522635-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Nov 15, 2007. Male patient, 78 years of age, was diagnosed with hepatic neoplasm malignant, hypertension and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation

, hypertension. Bevacizumab dosage: 10 MG/KG, Q2W. During the same period patient was treated with ERLOTINIB, LISINOPRIL, LOSARTAN POTASSIUM, NADOLOL, NEXIUM. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5571103-3
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 18, 2007. Male patient, 78 years of age, was diagnosed with hepatic neoplasm malignant, hypertension and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation

, hypertension. Bevacizumab dosage: 10 MG/KG, Q2W. During the same period patient was treated with ERLOTINIB, LISINOPRIL, LOSARTAN POTASSIUM, NADOLOL, NEXIUM. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5736177-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on May 09, 2008. Female patient, 48 years of age, weighting 127.9 lb, was diagnosed with head and neck cancer

and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion, disorientation, hypertension, leukoencephalopathy, nausea

, tonic clonic movements, visual disturbance. Bevacizumab dosage: 614 MG, Q 2 WKS, IV. During the same period patient was treated with CISPLATIN, TARCEVA. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5904015-3
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Sept 15, 2008. Female patient, 60 years of age, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion, deep vein thrombosis

, hypertension, pulmonary embolism

. Bevacizumab dosage: 10 MG/KG, Q2W. During the same period patient was treated with TEMOZOLOMIDE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5512611-0
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Nov 08, 2007. Male patient, 44 years of age, weighting 242.5 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: cholelithiasis, disease progression, hyperglycaemia, hypertension, pancreatitis acute. Bevacizumab dosage: 1230MG IV EVERY 2 WEEKS. During the same period patient was treated with TEMOZOLOMIDE, HYDROCHLOROTHIAZIDE, NEXIUM, XANAX, FLEXERIL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5173441-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 08, 2006. Female patient, weighting 152.8 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: grand mal convulsion, hypertension, hyponatraemia, nausea

, postictal paralysis. Bevacizumab dosage: 698MG QOW IV. During the same period patient was treated with IRINOTECAN, CARBATROL, PHENOBARBITAL, BONE CALCIUM. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5513722-6
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 08, 2007. Male patient, weighting 141.1 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: altered state of consciousness, convulsion, haemorrhagic stroke, hypertension, ischaemic stroke, nuclear magnetic resonance imaging brain abnormal, pyrexia. Bevacizumab dosage: 10 MG/KG. During the same period patient was treated with ERLOTINIB, LISINOPRIL, MINOCYCLINE, ATIVAN, MARINOL, TYLENOL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5513870-0
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 09, 2007. Male patient, weighting 141.1 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: haemorrhagic stroke, hypertension, ischaemic stroke, malignant neoplasm progression. Bevacizumab dosage: 10 MG/KG. During the same period patient was treated with ERLOTINIB, LISINOPRIL, MINOCYCLINE, ATIVAN, MARINOL, TYLENOL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5007331-5
Bevacizumab side effect was reported by a Physician from UNITED STATES on May 18, 2006. Female patient, weighting 169.1 lb, was diagnosed with endocrine pancreatic disorder, neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain

, aortic disorder, blood pressure diastolic decreased, chest pain

, condition aggravated, dehydration, haematoma, hypertension, jejunal ulcer. Bevacizumab dosage: 37.5 MG QS, Q 2 WEEKS, IV. During the same period patient was treated with DEXAMETHASONE, ALOXI, OXALIPLATIN, LEUCOVORIN CALCIUM. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5457513-3
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Sept 03, 2007. Female patient, weighting 116.8 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: hypertension, proteinuria, renal impairment. Bevacizumab dosage: 430 MG, Q3W. During the same period patient was treated with CAPECITABINE, MITOMYCIN, SOLPRIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5478664-3
Bevacizumab side effect was reported by a Consumer or non-health professional from SWITZERLAND on Sept 20, 2007. Male patient, weighting 209.9 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, hypertension, lethargy, pyrexia. Bevacizumab dosage: 475 MG, Q2W. During the same period patient was treated with FLUOROURACIL, FOLINIC ACID, ONDANSETRON. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5912839-1
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Sept 23, 2008. Female patient was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: aphasia

, hypertension, thyroid disorder, visual impairment. Bevacizumab dosage: unknown. During the same period patient was treated with ERLOTINIB. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5928589-1
Bevacizumab side effect was reported by a Health Professional from JAPAN on Oct 08, 2008. Male patient was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: blood creatinine increased, epilepsy

, hepatic failure, hyperammonaemia, hypertension, metastases to bone. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with IRINOTECAN, ISOVORIN, FLUOROURACIL, OXALIPLATIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5947512-7
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Oct 27, 2008. Female patient was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: aphasia

, headache

, hypertension, thyroid disorder. Bevacizumab dosage: unknown. During the same period patient was treated with ERLOTINIB. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5958225-X
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 07, 2008. Female patient was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: aphasia

, eye disorder, headache

, hypertension, thyroid disorder. Bevacizumab dosage: unknown. During the same period patient was treated with ERLOTINIB. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5442497-4
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Aug 20, 2007. Male patient was diagnosed with colorectal cancer

, colon cancer, pain

and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: depressed level of consciousness, embolism, hypertension, somnolence. Bevacizumab dosage: 5 MG/KG, QD. During the same period patient was treated with OXALIPLATIN, ISOVORIN, NIFEDIPINE, LOXOPROFEN, AMARYL, SENNOSIDE, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5523983-5
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 09, 2007. Male patient was diagnosed with colorectal cancer

, colon cancer, pain

and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: depressed level of consciousness, embolism, hypertension, somnolence. Bevacizumab dosage: 5 MG/KG, QD. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, ISOVORIN, NIFEDIPINE, LOXOPROFEN, AMARYL, SENNOSIDE, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5714525-X
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Apr 08, 2008. Male patient, weighting 123.5 lb, was diagnosed with colorectal cancer

, colon cancer, pain

and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: depressed level of consciousness, dysarthria, embolism, hypertension, proteinuria, somnolence. Bevacizumab dosage: 5 MG/KG, QD. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, ISOVORIN, NIFEDIPINE, LOXOPROFEN, AMARYL, SENNOSIDE, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5565705-8
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Dec 06, 2007. Male patient was diagnosed with colon cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: hypertension, oedema peripheral. Bevacizumab dosage: 5 MG/KG, UNK. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, ISOVORIN, NORVASC, OLMETEC, ZOFRAN, KYTRIL. Patient recovered.

Bevacizumab Side Effects Report #5601698-2
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Jan 10, 2008. Female patient was diagnosed with colon cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: hypertension, interstitial lung disease. Bevacizumab dosage: 5 MG/KG, UNK. During the same period patient was treated with ISOVORIN, FLUOROURACIL, OXALIPLATIN, MIYA BM, NORVASC, URSO, TATHION, MAGNESIUM OXIDE. Patient died on 10/28/2007.

Bevacizumab Side Effects Report #5954005-X
Bevacizumab side effect was reported by a Consumer or non-health professional from JAPAN on Oct 30, 2008. Male patient was diagnosed with colon cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: hypertension, oedema peripheral. Bevacizumab dosage: 5 MG/KG, UNK. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, LEUCOVORIN CALCIUM, NORVASC, OLMETEC, ZOFRAN, KYTRIL. Patient recovered.

Bevacizumab Side Effects Report #6029334-4
Bevacizumab side effect was reported by a Consumer or non-health professional from JAPAN on Oct 30, 2008. Male patient was diagnosed with colon cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: hypertension, oedema peripheral. Bevacizumab dosage: 5 MG/KG, UNK. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, CALCIUM LEVOFOLINATE, NORVASC, OLMETEC, ZOFRAN, KYTRIL. Patient recovered.

Bevacizumab Side Effects Report #6072220-4
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Jan 27, 2009. Male patient was diagnosed with colon cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: hypertension, pyrexia. Bevacizumab dosage: 340 MG, UNK. During the same period patient was treated with IRINOTECAN, FLUOROURACIL, LEUCOVORIN CALCIUM. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5450579-6
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Aug 29, 2007. Female patient was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dysarthria, hypertension, hypoaesthesia, muscular weakness. Bevacizumab dosage: 5 MG/KG, QD. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, ISOVORIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5464213-2
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Sept 07, 2007. Female patient was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dysarthria, hypertension, hypoaesthesia. Bevacizumab dosage: 5 MG/KG, QD. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, ISOVORIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5520062-8
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 02, 2007. Female patient was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dysarthria, hypertension, hypoaesthesia. Bevacizumab dosage: 5 MG/KG, QD. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, ISOVORIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5525838-9
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 12, 2007. Female patient was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: hypertension, interstitial lung disease, platelet count abnormal. Bevacizumab dosage: 5 MG/KG, UNK. During the same period patient was treated with ISOVORIN, FLUOROURACIL, OXALIPLATIN, MIYA BM, NORVASC, URSO, TATHION, MAGNESIUM OXIDE. Patient died on 10/28/2007.

Bevacizumab Side Effects Report #5529676-2
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 16, 2007. Male patient was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: hypersensitivity, hypertension. Bevacizumab dosage: 325 MG, UNK. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, ISOVORIN. Patient recovered.

Bevacizumab Side Effects Report #5622377-1
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Jan 28, 2008. Female patient was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dysarthria, hypertension, hypoaesthesia. Bevacizumab dosage: 5 MG/KG, QD. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, ISOVORIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5683165-3
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 13, 2008. Male patient was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hypersensitivity, hypertension. Bevacizumab dosage: 325 MG, UNK. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, ISOVORIN. Patient recovered.

Bevacizumab Side Effects Report #5724202-7
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Apr 10, 2008. Female patient was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: aortic arteriosclerosis, arrhythmia supraventricular, catheter related infection, hypertension, hypokinesia, intervertebral disc protrusion, lung infiltration, nodal arrhythmia, osteoarthritis

. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with ELOXATIN, LEUCOVORIN CALCIUM, FLUOROURACIL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5751096-6
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on May 13, 2008. Female patient was diagnosed with colon cancer, colon cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood urea increased, disease progression, epistaxis, hypertension, proteinuria, renal failure acute. Bevacizumab dosage: 5 MG/KG, UNK. During the same period patient was treated with OXALIPLATIN, LEUCOVORIN CALCIUM, FLUOROURACIL, CALCIUM GLUCONATE, MAGNESOL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5773109-8
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on May 29, 2008. Female patient was diagnosed with colon cancer, colon cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood urea increased, disease progression, epistaxis, hypertension, proteinuria, renal failure acute. Bevacizumab dosage: 5 MG/KG, UNK. During the same period patient was treated with OXALIPLATIN, CALCIUM LEVOFOLINATE, FLUOROURACIL, CALCIUM GLUCONATE, MAGNESOL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5960771-X
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 06, 2008. Male patient was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: hypersensitivity, hypertension, proteinuria. Bevacizumab dosage: 325 MG, UNK. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, LEUCOVORIN CALCIUM. Patient recovered.

Bevacizumab Side Effects Report #6110137-7
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 24, 2009. Male patient, weighting 202.8 lb, was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: hypertension, reversible posterior leukoencephalopathy syndrome. Bevacizumab dosage: 687.5 MG, Q3W. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, RAMIPRIL, BISOPROLOL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6138741-0
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 27, 2009. Male patient, weighting 202.8 lb, was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion, hypertension, reversible posterior leukoencephalopathy syndrome. Bevacizumab dosage: 687.5 MG, Q3W. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, RAMIPRIL, BISOPROLOL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5391543-5
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on July 04, 2007. Female patient, weighting 139.8 lb, was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dyspnoea, hypertension, pulmonary oedema. Bevacizumab dosage: 582 MG, Q2W. During the same period patient was treated with GEMCITABINE, VINORELBINE, ZOLEDRONIC ACID. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5418292-9
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Aug 08, 2007. Female patient, weighting 139.8 lb, was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: cardiac failure, dyspnoea, hypertension, pulmonary oedema. Bevacizumab dosage: 582 MG, Q2W. During the same period patient was treated with GEMCITABINE, VINORELBINE, ZOLEDRONIC ACID. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5572306-4
Bevacizumab side effect was reported by a Physician from UNITED STATES on Dec 17, 2007. Female patient was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: hypertension, pyrexia. Bevacizumab dosage: 1075 MG, UNK. During the same period patient was treated with ABRAXANE, LISINOPRIL, TYLENOL, ADVIL LIQUI, NEULASTA. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5757605-5
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on May 20, 2008. Female patient, weighting 205.0 lb, was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: blood urea increased, hypertension, vasculitis

. Bevacizumab dosage: 1400 MG, Q3W. During the same period patient was treated with PACLITAXEL, ELTROXIN, VASCACE, LIPITOR. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5771668-2
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on June 02, 2008. Female patient, weighting 205.0 lb, was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: blood urea increased, hypertension, leukocytoclastic vasculitis. Bevacizumab dosage: 1400 MG, Q3W. During the same period patient was treated with PACLITAXEL, ELTROXIN, VASCACE, LIPITOR. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5962466-5
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 07, 2008. Female patient was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diplopia, hypertension, paraplegia. Bevacizumab dosage: 1245 MG, Q3W. During the same period patient was treated with PACLITAXEL, NIFEDIPINE, FURANTHRIL, CHLORIDE, RINGER, VITAMIN B CAP, CEFUROXIME, MORPHINE. Patient was hospitalized. Patient died on 11/05/2008.

Bevacizumab Side Effects Report #5965141-6
Bevacizumab side effect was reported by a Physician from UNITED STATES on Nov 18, 2008. Female patient was diagnosed with breast cancer metastatic, hypertension, oral pain and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: hypertension, pyrexia. Bevacizumab dosage: 1075 MG, UNK. During the same period patient was treated with ABRAXANE, LISINOPRIL, TYLENOL, ADVIL, NEULASTA, BENICAR, MAGIC MOUTHWASH. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5973894-6
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 17, 2008. Female patient was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diplopia, hypertension, paraplegia. Bevacizumab dosage: 1245 MG, Q3W. During the same period patient was treated with PACLITAXEL, NIFEDIPINE, FURANTHRIL, CHLORIDE, RINGER, VITAMIN B CAP, CEFUROXIME, MORPHINE. Patient was hospitalized. Patient died on 11/05/2008.

Bevacizumab Side Effects Report #5443472-6
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 28, 2007. Female patient was diagnosed with breast cancer

and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: chest pain

, hypertension. Bevacizumab dosage: 1775 MG, Q3W. During the same period patient was treated with TAXOTERE, PROZAC, DARVON, KEFLEX, NIFEDIPINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5464502-1
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 11, 2007. Female patient was diagnosed with breast cancer

and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: chest pain

, hypertension. Bevacizumab dosage: 1775 MG, Q3W. During the same period patient was treated with TAXOTERE, PROZAC, DARVON, KEFLEX, NIFEDIPINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5554526-8
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 30, 2007. Female patient was diagnosed with breast cancer

and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: epistaxis, fatigue, hypertension, palmar-plantar erythrodysaesthesia syndrome, wound complication. Bevacizumab dosage: 420 MG, QD. During the same period patient was treated with DOXORUBICIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5579600-1
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Dec 19, 2007. Female patient was diagnosed with breast cancer

and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: epistaxis, fatigue, hypertension, palmar-plantar erythrodysaesthesia syndrome, wound complication. Bevacizumab dosage: 420 MG, QD. During the same period patient was treated with DOXORUBICIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5327395-9
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on May 01, 2007. Female patient was diagnosed with adenocarcinoma pancreas and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: confusional state, headache

, hypertension. Bevacizumab dosage: 10 MG/KG, DAYS 1+15. During the same period patient was treated with CETUXIMAB, GEMCITABINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5340657-4
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on May 14, 2007. Female patient was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion, hypertension. Bevacizumab dosage: unknown. During the same period patient was treated with SUNITINIB MALATE. Patient recovered.

Bevacizumab Side Effects Report #5351453-6
Bevacizumab side effect was reported by a Physician from UNITED STATES on May 30, 2007. Female patient was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion, hypertension. Bevacizumab dosage: unknown. During the same period patient was treated with SUNITINIB MALATE, ALLOPURINOL, ASCORBIC ACID, BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE, CALCIUM SUPPLEMENT, ESOMEPRAZOLE MAGNESIUM, FEXOFENADINE, LEVOTHYROXINE. Patient recovered.

Bevacizumab Side Effects Report #5742361-7
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on May 14, 2008. Female patient, weighting 200.6 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: chest pain

, dizziness

, dyspnoea, headache

, hypertension. Bevacizumab dosage: 439 MG. During the same period patient was treated with LEUCOVORIN CALCIUM, ELOXATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5749692-5
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on May 21, 2008. Female patient, weighting 200.6 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: chest pain

, dizziness

, dyspnoea, headache

, hypertension. Bevacizumab dosage: 439 MG. During the same period patient was treated with LEUCOVORIN CALCIUM, ELOXATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.

Bevacizumab and hypertension

SideEffects101.com

Bevacizumab and hypertension Patient Reports February 10, 2012

side effects of Bevacizumab